Literature DB >> 31474547

Stem cell stimulation continues to pay off in aplastic anaemia.

Phillip Scheinberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31474547     DOI： 10.1016/S2352-3026(19)30181-4

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  3 in total

Review 1.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162

Review 2.  Novel therapeutic choices in immune aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  F1000Res       Date:  2020-09-10

3.  Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.

Authors:  Jun Ho Jang; Yoshiaki Tomiyama; Koji Miyazaki; Koji Nagafuji; Kensuke Usuki; Nobuhiko Uoshima; Tomoaki Fujisaki; Hiroshi Kosugi; Itaru Matsumura; Ko Sasaki; Masahiro Kizaki; Masashi Sawa; Michihiro Hidaka; Naoki Kobayashi; Satoshi Ichikawa; Yuji Yonemura; Kouki Enokitani; Akira Matsuda; Keiya Ozawa; Kinuko Mitani; Jong Wook Lee; Shinji Nakao
Journal:  Br J Haematol       Date:  2020-11-05       Impact factor: 6.998
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.